Study reveals pancreatic cancer’s early immune evasion tactics

Pancreatic Cancer’s Hidden Start: How Early Detection is Shifting the Paradigm For years, pancreatic cancer has been notoriously difficult to treat, largely due to late diagnosis. But a groundbreaking new study from the Hebrew University of Jerusalem is changing our understanding of how this deadly disease begins, suggesting it may start preparing to evade the … Read more

Immune cells shape maternal and infant health during lactation

Breastfeeding: More Than Nutrition – The Emerging Role of Immunity For decades, breastfeeding has been lauded for its nutritional benefits for infants and its protective effects on maternal health. However, a growing body of research is revealing a far more complex picture: breastfeeding is fundamentally an immune process with lasting consequences for both mother and … Read more

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

Prostate Cancer Treatment Breakthrough: Combining Immunotherapy and Hormone Therapy Shows Promise A new study led by Mayo Clinic, published in Cell Reports Medicine, reveals a potentially game-changing approach to treating early-stage prostate cancer. Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery can overcome a significant hurdle in treatment – the … Read more

Study identifies antiviral protein IFN-γ as a potential biomarker for Long COVID fatigue

Unlocking Long COVID: The Role of IFN-γ and the Path to Personalized Treatment Millions worldwide continue to grapple with the debilitating effects of Long COVID, placing a significant strain on healthcare systems. Now, a groundbreaking study led by the University of Cambridge has identified the antiviral protein interferon gamma (IFN-γ) as a potential biomarker for … Read more

How magnetic heating technology could be a new cancer-fighting weapon

Mayo Clinic Pioneers “Induction Heating” for Cancer: A Recent Era in Targeted Therapy? Anyone who has used an induction cooker is halfway to understanding Mayo Clinic’s new experimental approach to killing cancer cells. The Rochester, Minnesota-based health system is the first in the U.S. To test a technology that uses heat to target and destroy … Read more

Discovery offers hope for reducing immune-related heart risks in cancer patients

Cancer Treatment Breakthrough: Reducing Heart Risks with New Insights into Immunotherapy For many cancer patients, immune checkpoint inhibitors (ICIs) like Keytruda and Opdivo have been life-changing. However, a potentially fatal side effect – inflammation of the heart tissue, known as myocarditis – has limited their apply. Now, researchers at Cincinnati Children’s Hospital have made a … Read more

Genome sequencing data reveals new insights into Epstein-Barr virus immunity

Unlocking the Secrets of Epstein-Barr Virus: A New Era of Immunity Research For decades, the Epstein-Barr virus (EBV) has remained a significant medical enigma. Present in approximately 90-95% of the global adult population, EBV is linked to cancers like Hodgkin’s lymphoma and autoimmune diseases such as multiple sclerosis. Now, groundbreaking research from the University Hospital … Read more

Macrophage immune memory depends on lingering interferon gamma

The Body’s Immune Memory: How Macrophages ‘Remember’ and What It Means for Autoimmune Diseases Our immune system isn’t just about reacting to threats; it’s about remembering them. For years, this “memory” was largely attributed to specialized cells like lymphocytes. However, a groundbreaking study from the University of California, Los Angeles (UCLA), published February 18 in … Read more

Antibody feedback reshapes B cell selection during immune response

The Immune System’s Self-Regulation: A New Era in Vaccine Design Researchers at the Ragon Institute, in collaboration with Scripps Research Institute, have revealed a surprising mechanism governing how the immune system selects the most effective B cells during an immune response. This discovery, published in Immunity, challenges the long-held belief that B cell selection is … Read more

Transcription factor HOXD13 drives melanoma growth and immune evasion

Melanoma Breakthrough: Targeting HOXD13 to Unlock Immune Response and Halt Tumor Growth Researchers have identified a key molecule, HOXD13, that fuels melanoma growth and simultaneously shields tumors from the body’s natural defenses. This discovery, spearheaded by teams at NYU Langone Health and its Perlmutter Cancer Center, offers a promising new avenue for treatment, potentially combining … Read more